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Abstract Acute/early HIV infection plays a critical role
in onward HIV transmission. Detection of HIV infections
during this period provides an important early opportunity
to offer interventions which may prevent further trans-
mission. In six US cities, persons with acute/early HIV
infection were identiﬁed using either HIV RNA testing of
pooled sera from persons screened HIV antibody negative
or through clinical referral of persons with acute or early
infections. Fifty-one cases were identiﬁed and 34 (68%)
were enrolled into the study; 28 (82%) were acute infec-
tions and 6 (18%) were early infections. Of those enrolled,
13 (38%) were identiﬁed through HIV pooled testing of
7,633 HIV antibody negative sera and 21 (62%) through
referral. Both strategies identiﬁed cases that would have
been missed under current HIV testing and counseling
protocols. Efforts to identify newly infected persons should
target speciﬁc populations and geographic areas based on
knowledge of the local epidemiology of incident infections.
Keywords Acute HIV infection  Nucleic acid
ampliﬁcation tests  HIV RNA testing  Early detection
of acute HIV infection
Introduction
There is compelling evidence that acute/early HIV infec-
tion plays a critical role in onward HIV transmission. Acute
HIV infection (AHI)—the period of weeks to about
2 months between HIV acquisition and completion of
seroconversion (Zetola and Pilcher 2007)—is characterized
by extremely high levels of virus in the blood and semen
(Pilcher et al. 2004a, b; Stekler et al. 2008), leading to
heightened infectiousness. Furthermore, although acute
HIV shedding is over about 10 weeks post-infection
(Zetola and Pilcher 2007), elevated onward transmission
likely extends through the period of early infection, deﬁned
as the 6 month period after seroconversion (Cates et al.
1997; Kassuto and Rosenberg 2004; Stekler et al. 2008),
due to ongoing high-risk behaviors (particularly if the
newly infected person is unaware of his or her recent
infection) (Cates et al. 1997; Koopman et al. 1997; Pao
et al. 2005). Sexually transmitted diseases (STDs)
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transmission risk (Gray et al. 2001; Pilcher et al. 2004a, b;
Pao et al. 2005). Finally, a transmission ampliﬁcation effect
may be expected because newly infected persons are likely
to transmit the virus to individuals engaging in similar
high-risk behaviors (Cates et al. 1997; Koopman, et al.
1997; Pilcher et al. 2005). Indeed, mathematical modeling
(Koopman et al. 1997), phylogenetic studies (Pao et al.
2005; Brenner et al. 2007; Lewis et al. 2008) and epide-
miologic studies (Wawer et al. 2005) indicate that high
rates of forward transmission last for at least 6 months
post-infection and that transmissions during this period
may account for as many as half of new infections.
For these reasons, diagnosis of acute/early HIV infection
followed by appropriate interventions to prevent further
transmission holds promise as an effective biomedical HIV
prevention strategy. However, the diagnosis of AHI, in
particular, is problematic because despite the high sensi-
tivity and speciﬁcity of currently used HIV antibody
assays, AHI represents a ‘‘window period’’ ranging from
weeks to about 2 month during which persons infected
with HIV will test HIV antibody negative or indeterminate
(Zetola and Pilcher 2007). To make the diagnosis of AHI,
the presence of the virus itself must be detected in the
blood using a plasma HIV RNA test. This can be accom-
plished through two strategies.
One strategy is a ‘‘public health approach’’ that incor-
porates routine screening of all HIV antibody negative or
indeterminate specimens into pools which are then tested
for HIV RNA (Flanigan and Tashima 2001; Quinn et al.
2000; Pilcher et al. 2005). Depending on the locality and
population tested this approach has been shown to increase
the detection of HIV infection approximately 4–10%
compared to antibody testing alone (Pilcher et al. 2005;
Priddy et al. 2007; Truong et al. 2006; Patel et al. 2006;
Stekler et al. 2005).
A second strategy is a ‘‘medical approach’’ in which
AHI is suspected based on clinical signs and symptoms
combined with a history of possible recent exposure, which
prompts speciﬁc diagnostic testing for AHI. An estimated
40–90% of persons with acute or recent HIV infection will
report symptoms consistent with the acute retroviral syn-
drome. These symptoms include ‘‘ﬂu-like’’ illness charac-
terized by fever, headache, muscle aches, joint pain,
swollen lymph nodes, sore throat, diarrhea, and/or rash, and
are similar to those found in other, more common viral and
bacterial infections, including infectious mononucleosis,
streptococcal pharyngitis, and cytomegalovirus infection
(Panel on Antiretroviral Guidelines for Adults and Ado-
lescents 2008; Kassutto and Rosenberg 2004; Zetola and
Pilcher 2007; Schacker et al. 1996). Unfortunately, the
mild and non-speciﬁc nature of the signs and symptoms
associated with the acute retroviral syndrome is a
signiﬁcant barrier to the diagnosis of AHI unless a clinician
entertains the diagnosis and orders appropriate virus-spe-
ciﬁc diagnostic tests (Weintrob et al. 2003; Sudarshi et al.
2008).
This is the ﬁrst in a series of ﬁve papers in this issue of
the journal (see Remien et al. 2009; Steward et al. 2009;
Atkinson et al. 2009; Kelly et al. 2009) that describe results
from the National Institute of Mental Health (NIMH)
Multisite Acute HIV Infection Study, an exploratory study
with the aims of determining the feasibility of detecting and
recruiting individuals with AHI into research studies; better
understanding the social and psychological context of
recent HIV transmissions; and assessing sexual behavior,
substance use, and the psychological state of individuals
during the periods before and after diagnosis. This research
provides formative results to inform development of
effective prevention interventions for persons with acute/
early HIV infection. In the present study, we describe the
two principal strategies used to identify and recruit study
participants and present their clinical, demographic, risk
behavior, HIV testing, and other selected characteristics.
Methods
The NIMH Multisite AHI Study was conducted at Brown
University (Providence, RI,); Colombia University (New
York City, NY,); University of California at Los Angeles
(Los Angeles, CA,); University of California at San Diego
(San Diego, CA,); University of California at San
Francisco (San Francisco, CA,); Medical College of
Wisconsin (Milwaukee, WI); and Yale University
(New Haven, CT).
We used both the public health and medical approaches
to identify AHI cases. The public health approach used
routine HIV RNA testing of pooled serum or plasma
samples that had yielded negative or indeterminate results
on standard HIV antibody tests. This approach was utilized
at sites attended by high risk individuals such as STD
clinics, HIV testing venues that served men who have sex
with men (MSM), and drug rehabilitation facilities. If a
pool was found to be positive, it was divided into smaller
pools and tested for HIV RNA until the individual(s) with
acute infection were identiﬁed. Pool sizes varied between
sites depending on the specimen volume and the time
requirements to report out ﬁnal results. Initial HIV anti-
body tests varied among the participating sites that tested
pooled samples: Vironostika HIV-1 Microelisa System
(viral lysate) (Biomerieux, Durham, NC) was used in Los
Angeles, New Haven, and San Francisco; HIV rapid testing
was performed using the Orasure whole blood test (Abbott,
North Chicago, Ill), the Clearview whole blood test
(Inverness, Waltham, Mass), or the OraQuick ADVANCE

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123Rapid HIV-1/2 Antibody Test (OraSure Technologies) in
Providence; and the latter test was also used in New Haven.
Specimens were tested for HIV RNA using RT-PCR
(Roche Ultrasensitive,Roche Diagnostics,Branchberg, NJ),
or GenProbe HIV-1 Aptima test (GenProbe, San Diego) in
Los Angeles; Versant HIV-1 RNA 3.0 bDNA Assay (Bayer
HealthCare) was used in New Haven, Providence, and San
Francisco.
The medical approach to identify individuals with AHI
involved referrals from clinical colleagues, including
experienced HIV providers, primary care providers for
high-risk persons, HIV test sites and several established
AHI clinical research programs. The diagnosis of AHI was
made after a provider clinically suspected AHI and an
initial negative or indeterminate HIV antibody test was
followed by a positive HIV RNA test. While our original
intent was to restrict study participation to persons diag-
nosed with AHI, due to the difﬁculty we encountered in
identifying such cases we decided to make a protocol
exception for six participants enrolled at the San Diego site
who were diagnosed in the stage of early HIV infection
based on positive initial HIV antibody/Western blot tests
combined with a prior recent (\6 months) negative HIV
antibody test.
The public health approach was utilized in Los Angeles;
the medical approach was utilized in New York and San
Diego; and both approaches were utilized in Providence,
New Haven, and San Francisco.
Study participants were 18 years of age or older, were
sufﬁciently proﬁcient in English to complete study mea-
sures, and were determined to be acutely infected (or
enrolled as a protocol exception as an early infection) as
described above. Participants met with a study recruiter
who explained the purpose of the research and obtained
written informed consent and tracking information. Par-
ticipants were asked to attend two interview sessions: the
ﬁrst targeted to be held within 4 weeks of the participant
being informed of his or her diagnosis and the second
targeted to be held 8 weeks later. At each session, partic-
ipants completed both a structured survey and an in-depth
interview. The study protocol was reviewed and approved
by the Human Subject’s Institutional Review Board in each
of the participating sites.
Results
Over an approximately 15 months period, 51 persons with
acute or early HIV infection were identiﬁed and 34 (67%)
were enrolled into the study [28 (82%) with AHI and 6
(18%) with early infections]: 6 (18%) were enrolled in
Providence; 6 (18%) in New York City; 9 (26%) in Los
Angeles; 6 (18%) in San Diego; 5 (15%) in San Francisco;
and 2 (6%) in New Haven. In spite of intensive efforts, one
site was unable to enroll participants. Thirteen (38%)
participants were identiﬁed through HIV RNA pooled
testing of 7,633 HIV antibody negative specimens and 21
(62%) were enrolled through clinical referral.
The demographic and other characteristics of partici-
pants are shown in Table 1; 32 (94%) were males, 15
(44%) were White, 13 (38%) were Hispanic, and 30 (88%)
were MSM. During the 2 months before diagnosis, 13
(38%) reported sex with an HIV-infected partner, 10 (29%)
reported meeting partner(s) on the Internet, 28 (82%)
reported anal intercourse, 22 (65%) reported using one or
more drugs, and 27 (79%) had multiple sex partners. Thirty
(88%) participants reported regular testing for HIV of
whom 25 tested every 6 months or less. During the
2 months before diagnosis, 14 participants (41%) reported
visits to a health care professional. Eight of these 14 (57%)
were seen in emergency departments, 5 of whom were seen
2 or 3 times.
The clinical characteristics and HIV test results of the
study participants are shown in Table 2. Twenty-one (62%)
patients presented with symptoms, consistent with the
acute retroviral syndrome, including fever, headache, rash,
muscle aches, sore throat, and swollen lymph glands. Five
participants (15%) reported symptoms more likely to be
due to an STD (e.g. pain on urination, penile chancre), and
eight (24%) participants were asymptomatic. Twelve
(35%) participants were known to be co-infected with
another sexually transmitted infection (6 were co-infected
with gonorrhea (GC) only, 3 with syphilis only, 2 with GC
and syphilis, and 1 with GC and Chlamydia (CT)).
Initial HIV viral loads were available for 32 participants:
14 (44%) had viral loads [500,000 copies/mL; 6 (19%)
were between 100,000 and 500,000 copies/mL; and 12
(38%) were\100,000 copies/mL.
Discussion
This study illustrates that both the public health and
medical referral strategies can be successfully utilized to
detect HIV infections that otherwise would not be diag-
nosed by standard antibody testing alone. Fifty-one indi-
viduals with acute or early HIV infection were identiﬁed
and 34 were enrolled at six US study sites over an
approximate 15 month study period. Of those enrolled, 13
(38%) were identiﬁed through pooled HIV RNA testing
of 7,633 HIV antibody negative specimens and 21 (62%)
were identiﬁed clinically, followed by HIV RNA or
repeat HIV testing. Relying only on HIV antibody and
Western blot assays performed once would have delayed
or missed the diagnosis for the 28 individuals who were
acutely infected.
AIDS Behav (2009) 13:1037–1045 1039
123Early detection of HIV infection allows appropriate
clinical management (Weintrob et al. 2003) including
treatment of STDs and the offer of partner counseling and
referral services, which can interrupt transmission to others
within an individual’s social and sexual network (Pilcher
et al. 2005; Hightow et al. 2005; Yerly et al. 2001). An HIV
diagnosis in itself, particularly in conjunction with
counseling interventions, is associated with a signiﬁcant
reduction in risk behavior (Colfax et al. 2002; Weinhardt
et al. 1999; Marks et al. 2005; Kalichman et al. 2001). We
observed this phenomenon in our sample (Steward et al.
2009).
Because mostcases ofHIV are currentlydiagnosed in the
chronicphase of infection(Pilcher et al. 2005), there is great
Table 1 Demographic and risk
characteristics of acute and
early HIV infection cases
detected through public health
and medical approaches,
N = 34
a Two month period before
diagnosis
Characteristics Detected through
public health approach
(n = 13) No. (%)
Detected through
medical approach
(n = 21) No. (%)
Total
(N = 34)
No. (%)
Age years [mean (SD)] 29 (7.5) 34 (10.6) 33 (9.5)
Gender
Male 13 (100) 19 (90.5) 32 (94.1)
Female – 2 (9.5) 2 (5.9)
Race/ethnicity
White 4 (30.8) 11 (52.4) 15 (44.1)
Hispanic 8 (61.5) 5 (23.8) 13 (38.2)
Black – 2 (9.5) 2 (5.9)
Other 1 (7.7) 3 (14.3) 4 (11.8)
Sexual orientation
MSM 12 (92.3) 18 (85.7) 30 (88.2)
Heterosexual 1 (7.7) 3 (14.3) 4 (11.8)
Education
High school or less 5 (38.5) 6 (28.6) 11 (32.4)
Some collage or collage graduate 6 (46.2) 13 (61.9) 19 (55.9)
Some graduate school or more 2 (15.4) 2 (9.5) 4 (11.8)
Year of income
$10,000 or less 3 (23.1) 8 (38.1) 11 (32.4)
$10,001–$20,000 3 (23.1) 4 (19.0) 7 (20.6)
$20,001–$40,000 5 (38.5) 3 (14.3) 8 (23.5)
Over $40,000 1 (7.7) 6 (28.6) 7 (20.6)
Declined to answer 1 (7.7) 0 (0.0) 1 (2.9)
Prior HIV testing behavior
Not tested regularly 1 (7.7) 3 (14.3) 4 (11.8)
Regularly tested, less frequently
than every 6 months
2 (15.4) 3 (14.3) 5 (14.7)
Regularly tested, at least once
every 6 month
10 (76.9) 15 (71.4) 25 (73.5)
Risk
a
Anal insertive sex 12 (92.3) 14 (66.7) 26 (76.5)
Anal receptive sex 10 (76.9) 14 (66.7) 24 (70.6)
Condom use (always) 2 (15.4) 4 (19.0) 6 (17.6)
Condom use (sometimes) 8 (61.5) 5 (23.8) 13 (38.2)
Methamphetamine use 5 (38.5) 6 (28.6) 11 (32.4)
Cocaine use 3 (23.1) 6 (28.6) 9 (26.5)
Poppers 4 (30.8) 11 (52.4) 15 (44.1)
Multiple partner 11 (84.6) 16 (76.2) 27 (79.4)
Sex with HIV? 4 (30.8) 9 (42.9) 13 (38.2)
Met partners on Internet 6 (46.2) 4 (19.0) 10 (29.4)
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of both the public health and medical approaches to AHI
diagnosis. The public health approach should target popu-
lations in which local epidemiologic trends suggest that
incident infections are occurring. Over one-third of partic-
ipantsinourstudywerefoundtobeco-infectedwithanSTD
(this was a minimum estimate because our protocol did not
require STD testing), suggesting that persons attending STD
clinics are one such population (Pilcher et al. 2005; Stekler
et al. 2005; Truong et al. 2006; Patel et al. 2006).
The majority of newly infected individuals, including
about three-fourths of the participants in our study, have
symptoms related to acute retroviral syndrome (Panel on
Antiretroviral Guidelines for Adults and Adolescents
2008; Zetola and Pilcher 2007; Kassutto and Rosenberg
2004; Schacker et al. 1996). Although symptoms prompt
many individuals to present for medical evaluation after
an infection event, AHI is rarely diagnosed (Schacker
et al. 1996; Weintrob et al. 2003; Sudarshi et al. 2008).
For the medical approach to AHI diagnosis to be suc-
cessful, clinicians must become more adept at recognizing
symptoms consistent with acute retroviral syndrome,
evaluating individuals’ risks for HIV acquisition,
employing HIV RNA testing when indicated, and appro-
priately interpreting results to optimize the timely diag-
nosis of AHI.
Clinicians should consider AHI in the differential
diagnosis of all individuals presenting with nonspeciﬁc
symptoms consistent with the acute retroviral syndrome
and a possible recent HIV exposure, take a thorough
sexual practice and drug use history, and order viral
speciﬁc testing or immediate repeat testing if the initial
HIV antibody test is negative. High risk individuals with
an STD who have a negative HIV antibody test should
be considered for reﬂex HIV RNA testing to rule out
AHI. Finally, provider education in the clinical and
counseling and testing setting should be continually
reinforced to minimize missed AHI detection opportu-
nities. The second paper of this series documents the
need for education and training programs about AHI for
populations-at-risk and for persons diagnosed with acute/
early infection, as well as for providers (Remien et al.
2009).
This study had several limitations. First, both the
public health and medical strategies to detect AHI were
not uniformly applied in all sites and the number of cases
identiﬁed by each method was small; therefore a direct
comparison of the two approaches is not possible. Second,
the cases we identiﬁed were primarily among MSM and
likely only represented the local at-risk populations that
had access to medical care or that sought HIV counseling
and testing services in the six cities participating in this
study.
Conclusions
These ﬁndings support the conclusion that both the public
health and medical strategies are able to identify cases of
AHI. However, pooled testing methods and speciﬁc diag-
nostic testing by clinicians will only succeed if these
strategies reach populations where incident infections are
occurring. Therefore, targeting speciﬁc populations within
a geographic area based on the local epidemiology of
incident infections with these strategies and efforts to
educate medical providers and staff in HIV testing and
counseling programs and at-risk communities about
symptoms and situations where AHI should be suspected
are likely to increase the diagnosis of AHI, opening the
way for appropriate referrals for medical care, partner
services and other behavioral interventions that may pre-
vent further transmission.
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